Lapovations Awarded $500K Phase IIB SBIR Matching Grant from National Science Foundation to Bolster Commercialization

Sep 14, 2023


This most recent award brings the total SBIR funding secured by Lapovations to $1.725M


Fayetteville, Arkansas Sep 13, 2023 (Issuewire.com) - Lapovations, LLC. Lapovations, a medical device company creating a platform of innovative products to improve laparoscopy, has been awarded a $500K Phase IIB Small Business Innovation Research (SBIR) matching grant from the National Science Foundation (NSF). This Phase IIB award follows $1.225M in Phase I and Phase II SBIR grants awarded to Lapovations in 2019 and 2020. AbGrab® is a revolutionary surgical assist device that allows surgeons to lift the abdominal wall more reliably and less invasively at the beginning of laparoscopy, or minimally invasive surgery of the abdomen.

The Phase IIB supplemental funding provides additional R&D funds to further accelerate the commercialization of Phase II projects when a qualifying third-party investment has been received as a direct consequence of the NSF-funded Phase I/Phase II research outcomes. For companies awarded a Phase IIB grant, NSF matches 50% of qualifying third-party investments, with a maximum award of $500K per company. The NSF matching funds are restricted to R&D-based activities that catalyze and fuel the commercialization of innovations developed in Phases I and II.

"Securing non-dilutive funding opportunities has been a crucial part of our capital strategy since inception", said Founder & CEO Jared Greer. "The $1.25M oversubscribed Series A we closed in January 2023 allowed us to maximize the $500K in non-dilutive matching funds from Phase IIB". Phase IIB brings the total grant funding secured by Lapovations to $1.725M since 2019.  

Nhiem Cao, COO at Lapovations, commented "This funding further verifies the commercial opportunity of AbGrab® and also validates our ongoing commercial efforts". AbGrab® was launched nationally in Q4 of 2022 and has sales representatives in 19 states across the US.

Though often the shortest part of a laparoscopic procedure, laparoscopic abdominal entry accounts for ~50% of serious laparoscopic complications and litigations related to laparoscopy(1,2). To reduce this risk, surgeons will lift the abdominal wall before entry, but current lifting techniques can be unreliable or invasive. AbGrab® uses suction to provide a more reliable, less invasive way to elevate the abdominal wall.

About Lapovations

Lapovations, LLC is a medical device company creating a platform of innovative products to improve laparoscopy or minimally invasive surgery of the abdomen. The company's first product, AbGrab®, is a novel device that uses suction to lift the abdominal wall at the start of the procedure. AbGrab® is more reliable and less invasive than current lifting methods. For more information contact: [email protected] or visit www.lapovations.com

1. Thepsuwan, J., Huang, K., Wilamarta, M., Adlan, A., Manvelyan, V. and Lee, C., 2013. Principles of safe abdominal entry in laparoscopic gynecologic surgery. Gynecology and Minimally Invasive Therapy, 2(4), pp.105-109 [Accessed 1 September 2021].

2. Jansen, F., Kolkman, W., Bakkum, E., de Kroon, C., Trimbos-Kemper, T. and Trimbos, J., 2004. Complications of laparoscopy: An inquiry about closed- versus open-entry technique. American Journal of Obstetrics and Gynecology, 190(3), pp.634-638 [Accessed 1 September 2021].

 

Media Contact

Lapovations


[email protected]

479-304-0436

700 W. Research Center Blvd., Suite 1437

http://www.lapovations.com

Source :Lapovations

This article was originally published by IssueWire. Read the original article here.

More News

Cavs hold off Pacers behind Harden’s 51-point night
Nov 21, 2026

Cavs hold off Pacers behind Harden’s 51-point night

CLEVELAND, Ohio — James Harden scored 51 points as the Cleveland Cavaliers defeated the Indiana Pacers, 128-119, in an NBA Cup game on Friday (Saturday in Manila). It was the 18-year veteran guard’s 26th 50-point game, passing the late Kobe Bryant for third-most 50-point games in NBA history. It was Harden’s first since he had 55 points for the Los Angeles Clippers against the Charlotte Hornets on Nov. 22, 2025. Harden is the 15th player to have a 50-point game for Cleveland. It was also his best scoring game with the Cavaliers since being acquired near the trade deadline in February. Harden was 15 of 26 from the field, including 7 of 11 from beyond the arc. He also made all 14 of his free throws along with six rebounds and six assists for the Cavaliers, who have won three of four and improved to 2-1 in East Group B. Donovan Mitchell added 20 points. Peyton Watson, who missed Wednesday’s game due to a lower back contusion after being injured on Monday against Chicago, scored 15. Ivica Zubac had 21 points and 10 rebounds, and Pascal Siakam scored 21 for the Pacers, who have dropped three straight and fell to 1-2 in East Group B. Cleveland was up 74-73 four minutes into the third quarter before going on a 21-4 run over a nearly four-minute span. Harden scored 13 during the spurt as he made all four of his shots from the field, including a pair of three-pointers. The Cavaliers’ largest lead was 113-90 with 7:39 remaining before the Pacers countered with a 21-4 run to make it a two-possession game with 2:03 left. Mitchell ended the spurt though with a basket on the ensuing trip. Meanwhile, Scottie Barnes scored 29 points, including a layup with 14 seconds left, and the Toronto Raptors ended their six-game losing streak with a 105-102 win over the Detroit Pistons. Toronto, which led by as many as 14, got the ball after a Detroit turnover with the score tied at 99. Barnes missed a driving layup, but Jakob Poeltl tipped it in to put the Raptors up 101-99 with 27.1 seconds to play.

Alcaraz brushes off injury to down Cobolli
Nov 21, 2026

Alcaraz brushes off injury to down Cobolli

TURIN, Italy — Carlos Alcaraz made light of any potential hamstring issues he may be facing as he eased to a 6-4, 6-1 victory over Flavio Cobolli in the ATP Finals on Friday, in the process booking a last-four meeting with Ben Shelton. Russia’s Daniil Medvedev later battled past American Frances Tiafoe, 6-3, 6-4, to snatch the final last-four berth and set up a clash with world No. 1 Alexander Zverev on Saturday. Third seed Alcaraz had an MRI scan on the thigh issue on Thursday but showed little sign that the heavy strapping on his left leg was hampering him as he needed just over an hour to dismiss the world No. 6 in Turin. With three victories from his three Ivan Lendl Group outings, Alcaraz has topped the pool and will face American Shelton on Saturday in a repeat of the Paris Masters final earlier in November. Alcaraz beat Shelton, 7-6 (7/5), 7-5, in the final in France to win the title for the first time, a measure of revenge on the American who had ended the Spaniard’s US Open title defense earlier in the season. “The challenge is not on the court now, it’s outside the court,” the 23-year-old Spaniard said. “I will do everything to be in better shape, physically, to be ready tomorrow (Saturday). It’s going to be a really important half of the day that I have ahead of me with my team, with my physio. “So we will see, but I think I’m doing great things. I felt great on court today.” Medvedev reached the ATP Finals semifinals for the fourth time and first since 2023. Both Medvedev and Tiafoe had beaten Cobolli but lost to Alcaraz earlier this week in the Ivan Lendl Group, leaving a winner-takes-all clash between the two. A missed backhand slice in the first set gave Medvedev the crucial break of serve, before Tiafoe lost his serve once again at 4-4 in the second set. Tiafoe saved three break points in the ninth game, but the seventh seed was unable to hold off Medvedev who served out for his 54th win of the season.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.